Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment. - Wikidata - wikimedia - TriplyDB

Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.

Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.

http://www.wikidata.org/entity/Q37160875

about

Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases

P2860

Q37107248-432A24C8-A3B8-4D50-B15D-264C6908F9CB

P2860

Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.

http://www.wikidata.org/entity/Q37160875

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 1982

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Urine cyclic nucleotide concen ...... l marker for cancer treatment.

@en

Urine cyclic nucleotide concen ...... l marker for cancer treatment.

@nl

type

label

Urine cyclic nucleotide concen ...... l marker for cancer treatment.

@en

Urine cyclic nucleotide concen ...... l marker for cancer treatment.

@nl

prefLabel

Urine cyclic nucleotide concen ...... l marker for cancer treatment.

@en

Urine cyclic nucleotide concen ...... l marker for cancer treatment.

@nl

P1433

Q37160875-D129781F-D4D0-4FAF-B5BE-305D2B7BA03E

P1476

Q37160875-B4C56070-2ED9-447E-8A23-E329F5AF9095

P2093

Q37160875-288B204F-C145-4B4F-A3C1-0D0D93CC63FB

Q37160875-5B3A8CBA-5148-44FF-9957-8EFC92E00B2E

Q37160875-6A65CA5A-F488-4009-93F5-F89ED59E98C3

Q37160875-75798648-7AC2-4E11-AA0D-1F3DE24519C1

Q37160875-9D44055C-7EF0-46AD-96E7-79C325281082

Q37160875-C3D2E6A7-0970-4D27-AE27-FC4692F7BE8D

Q37160875-C7911E40-86D5-4DFC-857F-86A776C03D38

Q37160875-D4FC22F2-B391-4AF1-A858-40DD42FD0FB8

P2860

Q37160875-02DE85A9-99AA-49F6-BFCB-7383C258C187

Q37160875-2A213F6F-D106-4721-8D51-703F3C226D53

Q37160875-6CBA9D7C-24E8-4FB2-A982-ABFCC7460288

Q37160875-80ECBF9C-DE9F-4C69-ACD8-8B1BFC2960D1

Q37160875-87ECCCB8-1FCA-4C88-86A2-ED182D8504C9

Q37160875-88AA280D-C877-4776-A6A8-D51D6023A9FC

Q37160875-892A5C37-507D-4BD3-84B5-8591B51FEA35

Q37160875-923DFD22-A5FE-418E-8ADC-1EAFC6839B05

Q37160875-ABEDAE3F-A7BD-438D-8326-B6E4DEDB9474

Q37160875-C4344B36-721F-4524-9662-71D3558198E8

P304

Q37160875-B21203E4-17A4-4B0B-B6F3-E21CE5503BD6

P31

Q37160875-CC581422-3357-4E95-A495-195AF14420F0

P356

Q37160875-345B0045-37C7-40B9-8DAE-4E0EB34BF23E

P407

Q37160875-CE8BC6B9-7FDD-45B5-A712-F2B8E61AF439

P433

Q37160875-CF41B261-0B45-438D-B400-81A4D49F74CC

P478

Q37160875-03659A1E-44B8-43A9-8D99-8ECDBA0693DD

P577

Q37160875-8DD84DCA-14F6-4C63-9136-3C9B2905CF8E

P5875

Q37160875-F71EDDBD-5DAE-4C16-846F-2E1F237C0EF8

P698

Q37160875-8596D8B8-AF29-43EA-B117-770430F51B25

P932

Q37160875-CEE758C4-19D3-4EBA-BF1B-1B6ACB55EAE7

P356

P1433

Journal of Clinical Pathology

P1476

Urine cyclic nucleotide concen ...... l marker for cancer treatment.

@en

P2093

Ellis RD

http://www.w3.org/2001/XMLSchema#string

Guthrie D

http://www.w3.org/2001/XMLSchema#string

Latner AL

http://www.w3.org/2001/XMLSchema#string

Monaghan JM

http://www.w3.org/2001/XMLSchema#string

Ross WM

http://www.w3.org/2001/XMLSchema#string

Skillen AW

http://www.w3.org/2001/XMLSchema#string

Turner GA

http://www.w3.org/2001/XMLSchema#string

Wilson RG

http://www.w3.org/2001/XMLSchema#string

P2860

Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: the Yin Yang hypothesis

Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.

Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.

The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.

Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

Studies on cyclic nucleotides in cancer. I. Adenylate guanylate cyclase and protein kinases in the prostatic sarcoma tissue.

Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.

Cyclic nucleotide phosphodiesterase activity of human normal and carcinomatous lung tissue.

Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors.

Adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate levels in human breast cancer tissue.

P304

800-806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.35.8.800

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

1982-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16909013

http://www.w3.org/2001/XMLSchema#string

P698

6286732

http://www.w3.org/2001/XMLSchema#string

P932

497792

http://www.w3.org/2001/XMLSchema#string